Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ANTI-KICKBACK PROHIBITION—SETTLEMENT AGREEMENTS: Drompé to pay $32M after self-disclosing FCA kickback scheme
    • ANTI-KICKBACK PROHIBITION—OIG ADVISORY OPINIONS: Referral service to connect audiology patients with hearing professionals would fall within the AKS safe harbor
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COVID-19—PRRB DECISIONS: Hospital’s deficient COVID-19 vaccination reporting triggers Medicare payment reduction
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CRITICAL ACCESS HOSPITALS—NOTICES: Notice of Supplemental Funding, Medicare Rural Hospital Flexibility Program
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS: Eleventh Circuit rejects one constitutional challenge but leaves open questions on FCA qui tam provisions
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—SEC And FDA Announce New MOU On Cooperation
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD—PROPOSED RULES: Green Innovation GmbH; Withdrawal of Food Additive Petition (Animal Use)
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE COMPLIANCE NEWS—OIG Work Plan updates for August 2026
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRODUCTS LIABILITY (DEVICES)–S.D. Cal.: Diabetic consumer’s state-law failure-to-warn tort claims against medical device manufacturer are preempted by the MDA
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—SEC And FDA Announce New MOU On Cooperation, (Sep 15, 2026)

    Law Firms Mentioned:Simpson Thacher & Bartlett
    Organizations Mentioned:Simpson Thacher

    By William B. Brentani, Vanessa K. Burrows, John Ericson, Richard A. Fenyes, William R. Golden, Hui Lin, Karen Hsu Kelley, Leslie Peng, Jacob Madden and Rebecca Rose of Simpson Thacher & Bartlett

    Public companies regulated by the U.S. Food and Drug Administration ("FDA") may encounter additional scrutiny of their statements to investors as a result of the FDA's new three-year memorandum of understanding ("MOU") with the U.S. Securities and Ex ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use